# Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study

> **NCT07509450** · NA · NOT_YET_RECRUITING · sponsor: **University Health Network, Toronto** · enrollment: 20 (estimated)

## Conditions studied

- Lymphoma Receiving CAR-T Therapy

## Interventions

- **BIOLOGICAL:** Fecal Microbial Transplant Enema
- **BIOLOGICAL:** Fecal Microbial Transplant Enema

## Key facts

- **NCT ID:** NCT07509450
- **Lead sponsor:** University Health Network, Toronto
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-04-15
- **Primary completion:** 2029-04-15
- **Final completion:** 2029-04-29
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2026-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07509450

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07509450, "Fecal Microbiota Transplantation in Patients Undergoing Chimeric Antigen Receptor T-cell Therapy and Allogeneic Stem Cell Transplant: A Pilot Study". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT07509450. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*